Oncolytics Biotech (ONCY)

Add to Watchlists
Create an Alert
1.54 -0.03  -1.91% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
ONCY Price Chart
View All Events

ONCY Events

Date Type Description
Mar 13 Earnings Q4 2013 Oncolytics Biotechâ® Inc. Earnings Results. Estimate: -0.08.
Nov 07 Earnings Oncolytics Biotechâ® Inc. Announces Third Quarter 2013 Results. Estimate: -0.06.
View All Performance Charts

ONCY Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Oncolytics Biotech is down 48.67% over the last year vs S&P 500 Total Return up 22.85%, Alkermes up 51.81%, and Jazz Pharmaceuticals up 163.5%.

Get Quote for

Portfolio Strategies Featuring ONCY

Did Oncolytics Biotech make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ONCY Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Canada
  • Headquarters State/Province: Alberta
  • Incorporation Country: Canada
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ONCY 1.54 -0.03 -1.91% 130.60M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.